Publication Name	World Journal of Psychiatry
Manuscript ID	86107
Country	China

Received	2024-01-12 03:37
Peer-Review Started	2024-01-12 03:37
To Make the First Decision
Return for Revision	2024-01-30 09:39
Revised	2024-02-26 14:25
Second Decision	2024-04-15 02:42
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-04-15 07:24
Articles in Press	2024-04-15 07:24
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-05-09 12:30
Publish the Manuscript Online	2024-05-16 07:58

ISSN	2220-3206 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Clinical Neurology
Manuscript Type	Retrospective Study
Article Title	Therapeutic effect and psychological impact of aspirin plus edaravone on patients with cerebral infarction
Manuscript Source	Unsolicited Manuscript
All Author List	Tian-Shu Wang and Li-Jun Jing
ORCID	Author(s) ORCID Number Tian-Shu Wang http://orcid.org/0009-0002-4241-5469
Funding Agency and Grant Number
Corresponding Author	Tian-Shu Wang, PhD, Doctor, Doctor, Department of Neurology, The First Affiliated Hospital of Zhengzhou University, No.1 Jianshe East Road, Zhengzhou 450052, Henan Province, China. fccwangts@zzu.edu.cn
Key Words	Aspirin; Edaravone; Cerebral infarction; Efficacy; Quality of life
Core Tip	Edaravone, a commonly used free radical scavenger in clinical practice, can reduce the concentration of hydroxyl radicals and inhibit lipid peroxidation activity, ultimately achieving effects such as reducing endothelial cell damage and delaying neuronal cell death. It is currently the main drug used for the treatment of acute cerebral infarction. In addition, it can theoretically play a synergistic role with aspirin to improve therapeutic effectiveness, but there are few relevant studies to confirm our view. This study confirmed that aspirin combined with edaravone has more prominent efficacy and other clinical advantages in the treatment of cerebral infarction patients.
Publish Date	2024-05-16 07:58
Citation	<p>Wang TS, Jing LJ. Therapeutic effect and psychological impact of aspirin plus edaravone on patients with cerebral infarction. <i>World J Psychiatry</i> 2024; 14(5): 644-652</p>
URL	https://www.wjgnet.com/2220-3206/full/v14/i5/644.htm
DOI	https://dx.doi.org/10.5498/wjp.v14.i5.644

Full Article (PDF)	WJP-14-644-with-cover.pdf
Manuscript File	86107_Auto_Edited-YJP.docx
Answering Reviewers	86107-Answering reviewers.pdf
Audio Core Tip	86107-Audio core tip.mp3
Biostatistics Review Certificate	86107-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	86107-Conflict-of-interest statement.pdf
Copyright License Agreement	86107-Copyright license agreement.pdf
Signed Informed Consent Form(s) or Document(s)	86107-Informed consent statement.pdf
Institutional Review Board Approval Form or Document	86107-Institutional review board statement.pdf
Non-Native Speakers of English Editing Certificate	86107-Language certificate.pdf
Peer-review Report	86107-Peer-review(s).pdf
Scientific Misconduct Check	86107-Bing-Zhang L-2.png
Scientific Editor Work List	86107-Scientific editor work list.pdf
CrossCheck Report	86107-CrossCheck report.pdf
CrossCheck Report	86107-CrossCheck.png